• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃肠道自主神经病变加剧成年 2 型糖尿病患者的肠道微生物失调。

Gastrointestinal Autonomic Neuropathy Exacerbates Gut Microbiota Dysbiosis in Adult Patients With Type 2 Diabetes Mellitus.

机构信息

Medical Faculty, Kunming University of Science and Technology, Kunming, China.

Endocrinology Branch, The First People's Hospital of Yunnan Province, Kunming, China.

出版信息

Front Cell Infect Microbiol. 2022 Feb 8;11:804733. doi: 10.3389/fcimb.2021.804733. eCollection 2021.

DOI:10.3389/fcimb.2021.804733
PMID:35211420
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8861497/
Abstract

OBJECTIVE

The diabetic autonomic neuropathy is one of the most common complications in type 2 diabetes mellitus (T2DM), especially gastrointestinal autonomic neuropathy (GAN), which occurs in up to 75% of patients. The study aimed to investigate the gut microbiota composition, structure, and function in T2DM patients with GAN (T2DM_GAN) and set up a link between gut microbiota and clinical characteristics of patients.

METHODS

DNA was extracted from fecal samples of three groups using the kit method: healthy volunteers (n = 19), the patients with T2DM (n = 76), and T2DM_GAN (n = 27). Sequencing of 16S ribosomal DNA was performed using the MiSeq platform.

RESULTS

According to the clinical data, higher age, lower triglyceride, and lower body mass index were the main features of patients with T2DM_GAN. The gut microbiota analysis showed that Bacteroidetes, Firmicutes, and Proteobacteria constituted the three dominant phyla in healthy individuals. In addition, the gut microbiota structure and function of T2DM_GAN patients were clearly different from that of T2DM patients. T2DM patients were characterized by Fusobacteria, Fusobacteriia, Fusobacteriales, Fusobacteriaceae, , , and . Those gut microbiota may be involved in carotenoid and flavonoid biosyntheses. Relatively, the Gammaproteobacteria, Enterobacteriales, Enterobacteriaceae, , , , and were characteristic in the T2DM_GAN patients. Those may be involved in bacterial invasion of epithelial cells and pathogenic infection.

CONCLUSIONS

GAN exacerbated gut microbiota dysbiosis in adult patients with T2DM. The findings indicated that phyla Fusobacteria and class Gammaproteobacteria were closely related to the occurrence of T2DM. Especially the latter may promote T2DM_GAN.

摘要

目的

糖尿病自主神经病变是 2 型糖尿病(T2DM)最常见的并发症之一,尤其是胃肠道自主神经病变(GAN),在多达 75%的患者中发生。本研究旨在探讨 T2DM 伴 GAN(T2DM_GAN)患者的肠道微生物群落组成、结构和功能,并建立肠道微生物群与患者临床特征之间的联系。

方法

采用试剂盒法从三组粪便样本中提取 DNA:健康志愿者(n=19)、T2DM 患者(n=76)和 T2DM_GAN 患者(n=27)。使用 MiSeq 平台对 16S 核糖体 DNA 进行测序。

结果

根据临床资料,T2DM_GAN 患者的主要特征为年龄较高、甘油三酯较低、体重指数较低。肠道微生物群分析表明,Bacteroidetes、Firmicutes 和 Proteobacteria 构成健康个体的三个主要门。此外,T2DM_GAN 患者的肠道微生物群结构和功能明显不同于 T2DM 患者。T2DM 患者的特征为 Fusobacteria、Fusobacteriia、Fusobacteriales、Fusobacteriaceae、、和。这些肠道微生物群可能参与类胡萝卜素和类黄酮的生物合成。相对地,T2DM_GAN 患者的特征为 Gammaproteobacteria、Enterobacteriales、Enterobacteriaceae、、、、和。这些可能参与细菌侵袭上皮细胞和致病性感染。

结论

GAN 加重了成年 T2DM 患者肠道微生物群的失调。研究结果表明,Fusobacteria 门和 Gammaproteobacteria 纲与 T2DM 的发生密切相关。特别是后者可能促进 T2DM_GAN 的发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6a/8861497/723a8be4a2ea/fcimb-11-804733-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6a/8861497/0bc33c325d1b/fcimb-11-804733-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6a/8861497/47fd03497dcb/fcimb-11-804733-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6a/8861497/680cd670857b/fcimb-11-804733-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6a/8861497/b39ef1bd0828/fcimb-11-804733-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6a/8861497/6b5793a6842f/fcimb-11-804733-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6a/8861497/e486bdc70c4e/fcimb-11-804733-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6a/8861497/723a8be4a2ea/fcimb-11-804733-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6a/8861497/0bc33c325d1b/fcimb-11-804733-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6a/8861497/47fd03497dcb/fcimb-11-804733-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6a/8861497/680cd670857b/fcimb-11-804733-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6a/8861497/b39ef1bd0828/fcimb-11-804733-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6a/8861497/6b5793a6842f/fcimb-11-804733-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6a/8861497/e486bdc70c4e/fcimb-11-804733-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6a/8861497/723a8be4a2ea/fcimb-11-804733-g007.jpg

相似文献

1
Gastrointestinal Autonomic Neuropathy Exacerbates Gut Microbiota Dysbiosis in Adult Patients With Type 2 Diabetes Mellitus.胃肠道自主神经病变加剧成年 2 型糖尿病患者的肠道微生物失调。
Front Cell Infect Microbiol. 2022 Feb 8;11:804733. doi: 10.3389/fcimb.2021.804733. eCollection 2021.
2
Alterations of gut microbiome in patients with type 2 diabetes mellitus who had undergone cholecystectomy.胆囊切除术后 2 型糖尿病患者肠道微生物组的改变。
Am J Physiol Endocrinol Metab. 2021 Jan 1;320(1):E113-E121. doi: 10.1152/ajpendo.00471.2020. Epub 2020 Nov 9.
3
Characteristics of gut microbiota in adult patients with type 1 and type 2 diabetes based on next‑generation sequencing of the 16S rRNA gene fragment.基于 16S rRNA 基因片段的下一代测序技术对 1 型和 2 型糖尿病成年患者肠道微生物组特征的研究。
Pol Arch Intern Med. 2018 Jun 30;128(6):336-343. doi: 10.20452/pamw.4246. Epub 2018 Apr 15.
4
Analysis of gut microbiota of obese individuals with type 2 diabetes and healthy individuals.分析 2 型糖尿病肥胖个体和健康个体的肠道微生物群。
PLoS One. 2019 Dec 31;14(12):e0226372. doi: 10.1371/journal.pone.0226372. eCollection 2019.
5
Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy.2 型糖尿病合并糖尿病视网膜病变患者肠道细菌微生物组的改变。
Sci Rep. 2021 Feb 2;11(1):2738. doi: 10.1038/s41598-021-82538-0.
6
SARS-CoV-2 infection alters the gut microbiome in diabetes patients: A cross-sectional study from Bangladesh.新型冠状病毒2型感染改变糖尿病患者的肠道微生物群:来自孟加拉国的一项横断面研究。
J Med Virol. 2023 Apr;95(4):e28691. doi: 10.1002/jmv.28691.
7
Gut Microbiome Dysbiosis in Patients with Endometrial Cancer vs. Healthy Controls Based on 16S rRNA Gene Sequencing.基于 16S rRNA 基因测序的子宫内膜癌患者与健康对照者的肠道微生物组失调。
Curr Microbiol. 2023 Jun 9;80(8):239. doi: 10.1007/s00284-023-03361-6.
8
The Association of Targeted Gut Microbiota with Body Composition in Type 2 Diabetes Mellitus.靶向肠道微生物群与 2 型糖尿病患者体成分的相关性研究。
Int J Med Sci. 2021 Jan 1;18(2):511-519. doi: 10.7150/ijms.51164. eCollection 2021.
9
Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals.比较 2 型糖尿病成年患者和健康个体的肠道微生物群。
Microb Pathog. 2017 Oct;111:362-369. doi: 10.1016/j.micpath.2017.08.038. Epub 2017 Sep 11.
10
Gut Microbiome Alterations and Functional Prediction in Chronic Spontaneous Urticaria Patients.慢性自发性荨麻疹患者的肠道微生物组改变和功能预测。
J Microbiol Biotechnol. 2021 May 28;31(5):747-755. doi: 10.4014/jmb.2012.12022.

引用本文的文献

1
Repeated faecal microbiota transplantation for individuals with type 1 diabetes and gastroenteropathy.对1型糖尿病合并胃肠病患者进行重复粪便微生物群移植。
Diabetologia. 2025 Sep 18. doi: 10.1007/s00125-025-06544-x.
2
The gut microbiome: a vital link to hyperuricemia, gout and acute flares?肠道微生物群:高尿酸血症、痛风及急性发作的关键联系?
Front Endocrinol (Lausanne). 2025 Aug 8;16:1643566. doi: 10.3389/fendo.2025.1643566. eCollection 2025.
3
Microbiota and enteric nervous system crosstalk in diabetic gastroenteropathy: bridging mechanistic insights to microbiome-based therapies.

本文引用的文献

1
Enzymatic Metabolism of Flavonoids by Gut Microbiota and Its Impact on Gastrointestinal Cancer.肠道微生物群对黄酮类化合物的酶促代谢及其对胃肠道癌症的影响。
Cancers (Basel). 2021 Aug 4;13(16):3934. doi: 10.3390/cancers13163934.
2
PICRUSt2 for prediction of metagenome functions.用于宏基因组功能预测的PICRUSt2
Nat Biotechnol. 2020 Jun;38(6):685-688. doi: 10.1038/s41587-020-0548-6.
3
Quyushengxin Formula Causes Differences in Bacterial and Phage Composition in Ulcerative Colitis Patients.祛湿生新方导致溃疡性结肠炎患者细菌和噬菌体组成的差异。
糖尿病性胃肠病中微生物群与肠神经系统的相互作用:将机制见解与基于微生物群的疗法相联系
Front Cell Infect Microbiol. 2025 Aug 11;15:1603442. doi: 10.3389/fcimb.2025.1603442. eCollection 2025.
4
Harnessing the oral-systemic axis: A novel frontier in cancer management.利用口腔-全身轴:癌症管理的新前沿。
Med Oncol. 2025 Jul 19;42(8):348. doi: 10.1007/s12032-025-02921-z.
5
Microbiome and metabolic disorder in prolactinoma: intrinsic gender differences and extrinsic therapy effects.泌乳素瘤中的微生物群与代谢紊乱:内在性别差异及外在治疗效果
Pituitary. 2025 Jul 3;28(4):83. doi: 10.1007/s11102-025-01544-x.
6
Engineering a Dual-Function Starch-Cellulose Composite for Colon-Targeted Probiotic Delivery and Synergistic Gut Microbiota Regulation in Type 2 Diabetes Therapeutics.设计一种用于结肠靶向益生菌递送和2型糖尿病治疗中协同调节肠道微生物群的双功能淀粉-纤维素复合材料。
Pharmaceutics. 2025 May 17;17(5):663. doi: 10.3390/pharmaceutics17050663.
7
Reduced abundance of signifies cardiovascular benefits of sodium glucose cotransporter 2 inhibitor in type 2 diabetes: a single arm clinical trial.钠葡萄糖协同转运蛋白2抑制剂对2型糖尿病患者心血管益处的相关指标丰度降低:一项单臂临床试验
Front Pharmacol. 2025 May 8;16:1600464. doi: 10.3389/fphar.2025.1600464. eCollection 2025.
8
A systematic review on gut microbiota in type 2 diabetes mellitus.关于2型糖尿病肠道微生物群的系统评价。
Front Endocrinol (Lausanne). 2025 Jan 17;15:1486793. doi: 10.3389/fendo.2024.1486793. eCollection 2024.
9
Probiotics alleviate painful diabetic neuropathy by modulating the microbiota-gut-nerve axis in rats.益生菌通过调节大鼠肠道微生物群-肠道-神经轴来缓解疼痛性糖尿病神经病变。
J Neuroinflammation. 2025 Feb 2;22(1):30. doi: 10.1186/s12974-025-03352-3.
10
Integrating 16S rDNA and metabolomics to uncover the therapeutic mechanism of electroacupuncture in type 2 diabetic rats.整合16S核糖体DNA和代谢组学以揭示电针治疗2型糖尿病大鼠的机制
Front Microbiol. 2025 Jan 6;15:1436911. doi: 10.3389/fmicb.2024.1436911. eCollection 2024.
Evid Based Complement Alternat Med. 2020 May 11;2020:5859023. doi: 10.1155/2020/5859023. eCollection 2020.
4
Phytochemicals and Gastrointestinal Cancer: Cellular Mechanisms and Effects to Change Cancer Progression.植物化学物质与胃肠道癌症:改变癌症进展的细胞机制和作用。
Biomolecules. 2020 Jan 8;10(1):105. doi: 10.3390/biom10010105.
5
Role of gut microbiota in type 2 diabetes pathophysiology.肠道微生物群在 2 型糖尿病发病机制中的作用。
EBioMedicine. 2020 Jan;51:102590. doi: 10.1016/j.ebiom.2019.11.051. Epub 2020 Jan 3.
6
Analysis of gut microbiota of obese individuals with type 2 diabetes and healthy individuals.分析 2 型糖尿病肥胖个体和健康个体的肠道微生物群。
PLoS One. 2019 Dec 31;14(12):e0226372. doi: 10.1371/journal.pone.0226372. eCollection 2019.
7
New indices regarding the dominance and diversity of communities, derived from sample variance and standard deviation.基于样本方差和标准差得出的有关群落优势度和多样性的新指标。
Heliyon. 2019 Oct 11;5(10):e02606. doi: 10.1016/j.heliyon.2019.e02606. eCollection 2019 Oct.
8
A survey of genes modulated by host cell infection.宿主细胞感染调节基因的调查。
Microb Genom. 2020 Feb;6(2). doi: 10.1099/mgen.0.000300. Epub 2019 Oct 29.
9
Gastrointestinal symptoms in patients with diabetes mellitus and non-diabetic: A cross-sectional study in north of Iran.糖尿病患者与非糖尿病患者的胃肠道症状:伊朗北部的一项横断面研究。
Diabetes Metab Syndr. 2019 May-Jun;13(3):2236-2240. doi: 10.1016/j.dsx.2019.05.028. Epub 2019 May 25.
10
Implications of the Intestinal Microbiota in Diagnosing the Progression of Diabetes and the Presence of Cardiovascular Complications.肠道微生物群在诊断糖尿病进展和心血管并发症中的意义。
J Diabetes Res. 2018 Nov 12;2018:5205126. doi: 10.1155/2018/5205126. eCollection 2018.